Analysts Opinion over Performance Valuation: Seattle Genetics, Inc. (NASDAQ:SGEN)

The Whalerock Point Partners Llc holds 36,190 shares with $1.97 million value, down from 48,790 last quarter. Ecor1 Capital Llc who had been investing in Regulus Therapeutics Inc for a number of months, seems to be bullish on the $127.87 million market cap company. About 15,598 shares traded.

From another technical standpoint, Seattle Genetics, Inc. It has outperformed by 85.30% the S&P500. SWN's SI was 44.85M shares in January as released by FINRA. With 13.06M avg volume, 3 days are for Southwestern Energy Company (NYSE:SWN)'s short sellers to cover SWN's short positions.

Cutera, Inc., a medical device company, designs, develops, makes, markets, and services laser and other energy based aesthetics systems worldwide. The stock decreased 0.91% or $0.05 during the last trading session, reaching $5.47. About 1.43M shares traded or 49.31% up from the average. Southwestern Energy Company (NYSE:SWN) has declined 41.00% since January 13, 2017 and is downtrending. It has underperformed by 89.90% the S&P500.

Investors sentiment decreased to 1.13 in Q3 2017. Its up 0.83, from 1.5 in 2017Q2.

Seattle Genetics, Inc. has a consensus outperform rating from 16 Wall Street analysts, and the number of shares now sold short amount to at least 9.01% of shares outstanding. 30 funds opened positions while 30 raised stakes.

The counter witnessed a trading volume of 2.97 million shares versus an average volume of 5.06 million shares during last trading session. Quantbot Technologies LP increased its position in shares of Seattle Genetics by 116.5% during the third quarter. California State Teachers Retirement System owns 157,451 shares or 0.02% of their USA portfolio. Cantor Fitzgerald set a $50.00 price objective on shares of Seattle Genetics and gave the stock a "hold" rating in a research report on Monday. The biotechnology company reported ($0.19) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.42) by $0.23. Profund Advsr Ltd Limited Liability Company reported 40,084 shares stake. Seattle Genetics had a negative return on equity of 32.41% and a negative net margin of 26.53%. (NASDAQ:SGEN) Performing Well? Us Savings Bank De reported 0% stake. Qs Investors Limited Liability Company has 0% invested in Seattle Genetics, Inc. Redmile Group LLC now owns 1,381,477 shares of the company's stock worth $55,825,000 after buying an additional 411,356 shares during the last quarter. 125,000 are held by Rock Springs Cap L P. Spark Invest Management Lc accumulated 0.54% or 183,500 shares. 2017, Seattle Genetics, Inc. (NASDAQ:SGEN). California-based Cap Ca has invested 0.49% in Seattle Genetics, Inc.

Rock Springs Capital Management Lp, which manages about $319.00M and $2.17B US Long portfolio, decreased its stake in Acadia Healthcare Company In (NASDAQ:ACHC) by 45,000 shares to 1.31 million shares, valued at $62.33 million in 2017Q3, according to the filing. State Board Of Administration Of Florida Retirement System reported 168,023 shares. Walleye Trading Ltd has 25,983 shares for 0% of their portfolio. Bloomin' Brands, Inc. (NASDAQ:BLMN) has risen 8.82% since January 13, 2017 and is uptrending. Therefore 100% are positive. More interesting news about Seattle Genetics, Inc. (NASDAQ:BLMN) earned "Hold" rating by Deutsche Bank on Wednesday, November 4. As per Friday, October 27, the company rating was maintained by RBC Capital Markets. The firm now has a hold rating on the biotechnology company's stock. (NASDAQ:MYGN) on Thursday, August 11 with "Hold" rating. The firm has "Neutral" rating by Credit Suisse given on Monday, December 12. Needham maintained Seattle Genetics, Inc. (NASDAQ:SGEN) has "Hold" rating given on Monday, June 26 by Oppenheimer. The stock has "Outperform" rating by RBC Capital Markets on Monday, October 10.

Since December 15, 2017, it had 0 insider buys, and 2 sales for $7.99 million activity. Shares for $501,176 were sold by SIMPSON TODD E on Wednesday, September 6. Moreover, Franklin Res Inc has 0% invested in Seattle Genetics, Inc.

In other news, insider Clay B. Siegall sold 14,465 shares of the business's stock in a transaction dated Friday, January 6th. DRACHMAN JONATHAN G sold 8,502 shares worth $407,199. (NASDAQ:BLMN) for 292,935 shares. National Planning Corp's holdings in Seattle Genetics were worth $6,787,000 as of its most recent SEC filing. (NYSE:MD) to report earnings on February, 6. They expect $-0.46 earnings per share, down 17.95% or $0.07 from last year's $-0.39 per share.

Seattle Genetics (NASDAQ:SGEN)'s stock had its "hold" rating reaffirmed by equities research analysts at Oppenheimer in a research report issued to clients and investors on Tuesday, January 2nd. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. Therefore 100% are positive. JPMorgan Chase & Co. reissued a "hold" rating on shares of Seattle Genetics in a research note on Tuesday. The company was maintained on Wednesday, August 16 by Oppenheimer. The rating was maintained by Cowen & Co with "Hold" on Thursday, July 27. The firm has "Underperform" rating given on Tuesday, November 17 by Sterne Agee CRT. The company was maintained on Tuesday, September 15 by Mizuho. The rating was downgraded by Boenning & Scattergood to "Neutral" on Wednesday, October 25. The company was initiated on Monday, October 23 by Guggenheim. Cantor Fitzgerald has "Hold" rating and $4300 target.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.